Variables | < 40 years old | ≥ 40 years old | ||
---|---|---|---|---|
OR(IC) | p-value | OR(CI) | p-value | |
Age (continuous) | 1.12 (1.05 – 1.20) | 0.001 | 1.11 (1.05 – 1.17) | < 0.001 |
Male sex | 2.77 (1.43 – 5.34) | 0.002 | 1.62 (0.94 – 2.81) | 0.080 |
Nonwhite | 3.01 (1.23 - 6.53) | 0.007 | 1.37 (0.73 – 2.57) | 0.321 |
BMI overweight | 1.65 (0.79 – 3.44) | 0.344 | 1.93 (1.04 – 3.57) | 0.036 |
Obese | 5.13 (1.79 – 14.7) | 0.002 | 2.53 (0.85 – 7.54) | 0.095 |
Metabolic Syndrome | 3.30 (1.44 – 7.58) | 0.005 | 1.01 (0.54 – 1.88) | 0.968 |
Total cholesterol <200 | 1.0 | 1.0 | ||
200 to < 240 mg/dL | 0.83 (0.32 - 2.03) | 0.701 | 1.24 (0.66 – 2.32) | 0.491 |
≥ 240 mg/dL | 2.28 (0.83 – 9.40) | 0.095 | 2.14 (0.76 – 5.98) | 0.145 |
Stable partner | 2.07 (1.03 – 4.19) | 0.041 | 2.41 (1.24 – 4.67) | 0.009 |
CD4+ T-lymphocytes <200 | 1.0 | 1.0 | ||
200 to < 350 cels/mm3 | 0.86 (0.33 – 2.24) | 0.758 | 1.18 (0.59 – 2.37) | 0.631 |
≥ 350 cels/mm3 | 0.71 (0.24 – 2.09) | 0.542 | 2.81 (1.22 – 6.47) | 0.015 |
HAART duration of use | ||||
No HAART use | 1.0 | 1.0 | ||
PI < 5 years | 0.64 (0.27 – 1.54) | 0.323 | 0.67 (0.32 – 1.39) | 0.287 |
PI ≥ 5 years | 2.15 (0.23 – 20.1) | 0.503 | 1.81 (0.38 – 8.59) | 0.453 |
NNRTI < 5 years | 1.52 (0.74 – 3.08) | 0.248 | 1.31 (0.66 – 2.60) | 0.426 |
NNRTI ≥ 5 years | 1.94 (0.62 – 6.07) | 0.254 | 2.65 (1.10 – 6.37) | 0.028 |